medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2021, Number 4

<< Back

Rev Mex Patol Clin Med Lab 2021; 68 (4)

Serious anemia and sanguinea incompatibility. Medical management in emergency situations

Escamilla-González J, Ríos-Ayala MA, Garza-De MA, Monares-Zepeda E

Language: Spanish
References: 28
Page: 195-201
PDF size: 233.13 Kb.


ABSTRACT

Urgent transfunctional support represents a common practice in critical care, therefore, the approach to study blood compatibility and therapeutic options in case of incompatibility must be well identified by non-hematologist doctors to be able to choose in serious situations The best strategy that represents the lowest risk. We review the protocol of care step by step in cases of incompatibility and we focus on the therapeutic options that have proven to be safe in the care of critical patients, especially in emergency clinical situations, since no protocol of so far is described action that regulates the transfucional support in these clinical scenarios.


REFERENCES

  1. Petz LD. "Least incompatible" units for transfusion in autoimmune hemolytic anemia: should we eliminate this meaningless term? A commentary for clinicians and transfusion medicine professionals. Transfusion. 2003; 43: 1503-1507.

  2. Weinstein R. Red blood cell transfusion. A pocket guide for the clinician. 2016. The American Society of Hematology.

  3. Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ et al. Williams hematology. Chapter XIII, 9th ed. United States of America. McGraw-Hill, 2016.

  4. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007; 21 (1): 58-71.

  5. Kleinman S, Nelson R, Smith L, Goldfinger D. Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide. N Engl J Med. 1984; 311: 809-812.

  6. Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol. 2005; 42: 137-144.

  7. Petz L. Blood transfusion in acquired hemolytic anemias. In: Petz LD, Swisher SN (Editor). Clinical practice of transfusion medicine, Churchill Livingstone, New York 1996, 469.

  8. Gilliland B. Autoimmune hemolytic anemia. In: Rossi E (Ed). Principles of transfusion medicine. Williams Wilkins, Baltimore 1996, 101.

  9. Salama A, Berghofer H, Mueller-Eckhardt C. Red blood cell transfusion in warm-type autoimmune haemolytic anaemia. Lancet. 1992; 340: 1515.

  10. Sokol RJ, Hewitt S, Booker DJ, Morris BM. Patients with red cell autoantibodies: selection of blood for transfusion. Clin Lab Haematol. 1988; 10: 257.

  11. Garratty G. Mechanisms of immune red cell destruction, and red cell compatibility testing. Hum Pathol. 1983; 14: 204.

  12. Bhattacharya P, Samanta E, Afroza N, Naik A, Biswas R. An approach to incompatible cross-matched red cells: our experience in a major regional blood transfusion center at Kolkata, Eastern India. Asian J Transfus Sci. 2018; 12: 51-56.

  13. Milkins C, Berryman J, Cantwell C et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med. 2013; 23 (1): 3-35.

  14. International Society of Blood Transfusion, Red Cell Immunogenetics and Blood Group Terminology. [Accessed 24 March 2016] Available in: http://www.isbtweb.org/working-parties/red-cell-immunogeneticsand-blood-group-terminology

  15. Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology. 2009; 25 (2): 48-59.

  16. Chou ST, Westhoff CM. The Rh and RhAG blood group systems. Immunohematology. 2010; 26 (4): 178-186.

  17. Shirey RS, Boyd JS, Parwani AV et al. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion. 2002; 42: 1435-1441.

  18. Reid ME. Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion. 2003; 43: 1748-1757.

  19. Silvergleid AJ, Wells RF, Hafleigh EB et al. Compatibility test using 51chromium-labeled red blood cells in crossmatch positive patients. Transfusion. 1978; 18 (1): 8-14.

  20. Chiaroni J, Gouvitsos J, Dettori I, Ferrera V. How we evaluate panagglutinating sera. Transfusion. 2009; 49: 1540-1545.

  21. Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion. 2008; 48: 2069-2076.

  22. Harmening DM. Modern blood banking and transfusion practices. 5th ed, F.A. Davis Company, Philadelphia, 2005.

  23. Petz L, Garratty G. Immune hemolytic anemias. Churchill Livingstone, New York 2004.

  24. Win N, Needs M, Thorton N, Webster R, Chang C. Transfusion of least incompatible blood with intravenous immunoglobin plus steroids cover in two patients with rare antibody. Tranfusion. 2018; 58 (7): 1626-1630.

  25. Keir AK, Wilkinson D, Andersen C, Stark MJ. Washed versus unwashed red bood cells for transfusion for the prevention of morbidity and mortality in preterm infants. Cochrane Database of Systemic Reviews. 2016; 2016 (1): CD011484.

  26. Svensson AM, Bushor S, Fung MK. Case report: exacerbation of hemolytic anemia requiring multiple incompatible RBC transfusions. Immunohematology. 2004; 20: 177-183.

  27. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014; 99 (10): 1547-1554.

  28. Anderson D, Ali K, Blanchette V et al. Guidelines on the use of intravenous immunoglobulin for hematologic conditions. Transfus Med Rev. 2007; 21 (2 Suppl 1): S9-56.




2020     |     www.medigraphic.com